P&G fiscal 2026 results: consumer staples sector performance check

Key takeaways

• Procter & Gamble’s fiscal 2026 results, filed with an 8-K on July 29, 2026, give a read on consumer staples sector performance.
• Fiscal-year net sales rose 3% to $87.0 billion, but organic sales grew just 1%, with flat volume and 1% pricing.
• Fourth-quarter organic sales were flat and diluted EPS fell 15% to $1.26; core EPS fell 3% to $1.43.
• Beauty was the only segment with clear organic growth in the quarter, at 4%.
• Fiscal 2027 guidance calls for 1% to 3% organic sales growth and core EPS of $6.89 to $7.11.

A year of slow growth

Procter & Gamble’s fiscal 2026, which ended June 30, showed how hard it has become for the largest household goods makers to grow. Net sales reached $87.0 billion, up 3%, but most of that gain came from currency. Organic sales, which strip out foreign exchange and acquisitions, rose 1%. Volume was flat, pricing added 1% and foreign exchange added 2%.

Diluted EPS for the year was $6.62, up 2%, and core EPS, which excludes items such as restructuring charges, was $6.89, up 1%. Net earnings were $16.1 billion, and operating cash flow came to $19.6 billion. Gross margin narrowed by 100 basis points to 50.2%, with a core gross margin of 50.7%.

Fourth-quarter detail by segment

The fourth quarter, covering April through June, was weaker than the full year. Net sales rose 2% to $21.2 billion, but organic sales were flat. Diluted EPS fell 15% to $1.26, and core EPS declined 3% to $1.43.

Segment	Q4 organic sales growth
Beauty	+4%
Grooming	0%
Health Care	-1%
Fabric & Home Care	0%
Baby, Feminine & Family Care	-2%

Beauty was the only segment to post organic growth. Fabric and Home Care and Grooming were flat, while Health Care and Baby, Feminine and Family Care declined. For a portfolio built on everyday necessities, flat organic sales across most categories show how little growth the business found in the quarter beyond Beauty.

Restructuring and one-time items

The gap between diluted and core EPS reflects a restructuring program announced in June 2025, which the company expects to cost $1 billion to $1.6 billion before tax over two years, with more than half incurred in fiscal 2026. The year also included an after-tax gain of $261 million from Clorox’s purchase of P&G’s minority interest in the Glad joint venture.

Cash returns

P&G paid $10.2 billion in dividends and repurchased $5.0 billion of stock, returning $15.2 billion to shareholders. The company said fiscal 2026 marked the 70th consecutive year it has raised its dividend. For fiscal 2027 it plans about $10 billion in dividends and about $5 billion in buybacks.

Fiscal 2027 outlook

Guidance for fiscal 2027 calls for net sales and organic sales growth of 1% to 3%, diluted EPS growth of 1% to 5%, and core EPS growth from flat to 3%, a range of $6.89 to $7.11. The company expects adjusted free cash flow productivity of 85% to 90% and capital spending of 4.5% to 5.5% of net sales. It flagged a combined headwind of $0.56 per share from raw materials, energy, transportation, interest expense and foreign exchange. Measured against the core EPS base of $6.89, that headwind equals about 8% of earnings, which shows how much cost savings and pricing the company needs simply to hold profits steady.

What to watch for sector performance

For investors gauging sector performance in consumer staples, the main questions are whether volume returns to growth, whether Beauty’s momentum spreads to other categories, and how much of the $0.56 headwind the company can offset with productivity savings. This summary reports the filing and does not make a recommendation on the shares.